# Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

> **NCT02661347** · NA · WITHDRAWN · sponsor: **Northwell Health**

## Conditions studied

- Schizophrenia
- Schizophreniform
- Schizoaffective Disorder
- Psychosis Not Otherwise Specified (NOS)

## Interventions

- **DRUG:** Risperidone
- **DEVICE:** tDCS

## Key facts

- **NCT ID:** NCT02661347
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2016-12-01
- **Final completion:** 2016-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulty in recruiting patients who met the eligibility criteria.
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661347, "Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02661347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*